Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3 results about "Neurasthenia" patented technology

Neurasthenia is a term that was first used at least as early as 1829 to label a mechanical weakness of the nerves and would become a major diagnosis in North America during the late nineteenth and early twentieth centuries after neurologist George Miller Beard reintroduced the concept in 1869.

Wild ganoderma product for resisting cancer and tumor and removing liver toxin and preparation technology

InactiveCN108968031AGood anti-corrosion and fresh-keeping effectStrengthen cancer treatmentFruit and vegetables preservationFood ingredient functionsDiseaseNasopharyngeal carcinoma
The invention discloses a wild ganoderma product for resisting cancer and tumor and removing liver toxin and a preparation technology. According to the invention, wild ganoderma lucidum is adopted asraw material, and the wild ganoderma product for resisting cancer and tumor and removing liver toxin is finally prepared by the steps of washing, sterilizing, drying and dicing and the like. The product has the advantages of inhibiting cancer cell growth, attending acute and chronic hepatitis, early cirrhosis, esophageal cancer, lung cancer, liver cancer, nasopharyngeal carcinoma, pancreatic cancer, neurasthenia, intestinal diarrhea, rheumatoid tuberculosis,diabetes, gastrointestinal diseases, nourishing physical, lowering blood sugar, moistening the lungs and kidneys, maintaining beauty and keeping young, enhancing immunity, and enriches in ergosterol, ganoderic acid, ganoderma lucidum polysaccharides, amino acids, polypeptides, adenosine, triterpenoids and various trace elements, whereinthe organic germanium content is as high as 12380 ppm and the organic selenium content is also high. The product can be made into five-color ganoderma lucidum tea, ganoderma lucidum beverage, ganoderma lucidum oral liquid, five-color ganoderma lucidum wine, and other homologous products of medicines and foods. The product provided by the invention can also be made into traditional Chinese medicine prescriptions such as paste, pill and pellet.
Owner:深圳玺越建材科技有限公司

Traditional Chinese medicine composition for treating neurasthenia with unquiet spirit

InactiveCN104758561AIndications of restlessnessIndications for insomnia and dreaminessNervous disorderMolluscs material medical ingredientsSaposhnikoviaAdemetionine
The invention discloses a traditional Chinese medicine composition for treating neurasthenia with unquiet spirit, which is composed of following raw materials, by weight: 10-18 parts of spina date seeds, 20-40 parts of nacre mother of pearl, 10-18 parts of rhizoma anemarrhenae, 14-22 parts of poria cocos, 8-16 parts of rhizome chuanxiong, 4-12 parts of radix glycyrrhizae, 14-22 parts of prepared radix rehmanniae, 10-18 parts of lily, 20-30 parts of albizzia julibrissin, 10-18 parts of centipede, 8-16 parts of adenophora stricta, 12-20 parts of radix pseudostellariae, 10-18 parts of asparagus cochinchinensis, 6-14 parts of divaricate saposhnikovia roots, 16-24 parts of tuber fleeceflower stems and 10-18 parts of sclerotia of poria cocos. The traditional Chinese medicine, through tonifying heart to quiet spirit, is mainly used for treating following symptoms: uneasy feeling, insomnia and dreamful sleep, dysphoria, heavy head and fatigue body, light sleep, red tongue and thin pulse.
Owner:李博
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products